Ozempic rebound

Also called GLP-1 weight regain, post-Ozempic regain.

Dr Chad OkayFounder, Suna Health

4 min read. Updated .

Ozempic rebound is the weight regain that follows stopping a GLP-1 medication. Trial data show most people regain about two thirds of lost weight within a year of stopping. The mechanism is straightforward: appetite signalling returns to baseline, and the food restriction that drove the loss isn't sustained without the drug. Strategies that limit rebound: gradual taper, sustained protein and strength training, and (most reliably) treating GLP-1 as long-term therapy.

Why the rebound happens

GLP-1 drugs work by quieting hunger and reward signals from the gut and brain. When you stop, those signals return toward baseline. If your eating habits during weight loss were sustained primarily by the drug rather than by built habit, calorie intake creeps back up. Worse, after weight loss the body becomes more efficient at storing energy (a real phenomenon called metabolic adaptation), so the same calories produce more weight gain than before.

What the data shows

  • STEP 1 trial extension: 17.3% average weight loss on Wegovy at 68 weeks. After stopping, two thirds regained at 1 year.
  • STEP 4 trial: continuing Wegovy after 20 weeks led to ongoing weight loss; switching to placebo led to regain.
  • SURMOUNT-4 (Mounjaro): similar pattern. Continuing produced sustained loss; stopping produced ~67% regain of weight lost (Aronne 2024 JAMA, ~14% regain on placebo arm after losing 20.9%).
  • Average rebound trajectory: most regain in the first 6 months; rate slows after a year; in trial follow-up to 88-120 weeks, participants who stopped remain net BELOW their starting weight (STEP 1 ext: -5.6% at week 120; SURMOUNT-4 placebo: -9.9% at week 88). Long-term (>2 yr) post-discontinuation data are limited.

What limits rebound

  1. Step down through doses rather than stopping at the maximum, though no trial has shown a taper reduces regain versus an abrupt stop.
  2. Build muscle during the loss phase. Strength training during weight loss helps preserve lean mass.
  3. Eat 1.6-2.2 g protein per kg body weight daily during loss AND maintenance.
  4. Maintain the eating habits formed on the drug. The drug taught your appetite a new normal; protect it.
  5. Keep weighing yourself weekly post-stop. Catching 2 kg of regain is easier than catching 8 kg.
  6. Restart or switch the drug if regain exceeds 5% of body weight despite the above. Increasingly the standard approach.
  7. Most realistic strategy: treat GLP-1 as long-term therapy, like blood pressure medication. Most weight-management specialists now recommend this.

Why people stop

  • Cost (private GLP-1s are £200-300/month long-term).
  • Side effects (chronic nausea, constipation, reflux).
  • Pregnancy or trying to conceive.
  • Reached goal weight and want to see if they can maintain.
  • Medication shortages.
  • Insurance coverage changes (mostly US).

If you must stop

  • Time it deliberately. Don't stop during high-stress periods.
  • Set a maintenance plan in writing before the last dose.
  • Schedule weekly weigh-ins for at least 6 months post-stop.
  • Restart the drug (or switch to a different GLP-1) if you regain more than 5% of body weight.

If something feels wrong

This entry is reference information, not medical guidance. Your doctor and pharmacist know you and your medicine; if anything about how you feel worries you, speak to them promptly, and if you ever feel seriously unwell, treat it as an emergency. The medicine's own patient information leaflet carries the important safety information and is worth reading in full.

Common questions

Will I gain ALL the weight back?
Usually not all, but most. Trial data shows about two thirds of lost weight returns within a year of stopping. So someone who lost 15% typically regains about 10% and stabilises at 5% below their starting weight. Variable by individual.
Is the rebound the drug's fault?
No. The drug worked while taken. Stopping a chronic-condition medication usually leads to the condition returning. We don't blame blood pressure drugs for blood pressure rising when stopped.
Can microdosing prevent rebound?
Some clinics offer maintenance doses below the standard therapeutic level, but evidence is early. Anecdotally many people maintain on lower doses after reaching goal weight. Discuss with your prescriber.
Will I be on this for life?
Increasingly the framing in obesity medicine. Just as someone taking a statin for cholesterol or a blood pressure pill for hypertension expects to take it indefinitely, GLP-1s are moving toward long-term use. The economic and social implications are real and unresolved.

Sources

Written by Dr Chad Okay. Contributor: Dr Parisah Hussain, MBChB, BSc (Hons), DRCOG, MRCGP. Last updated 17 September 2026. From Digests.

Digests explains how the body works in general, everyday terms. It is not medical advice. It is not a substitute for someone who can examine you and knows your history, and we do not tell you what dose of any medicine to take.

Where we describe how something is checked or looked after, we follow UK guidance from NICE and the NHS. If you are reading this outside the UK, the same concerns are worth taking to your own doctor, though the tests and routes where you live may differ.

Suna Health is building a wearable wellness device for gut health, and you will see it advertised alongside these pages. That commercial interest does not decide what the content says.

If you think we have got something wrong, tell us at digests@suna.health. It goes to the editor. Full terms, including our liability position, are at suna.health/terms.